$RVVTF Revive Therapeutics Signs MOU with Attwill Medical Solutions for Phase 3 Clinical Trial for Bucillamine in COVID-19 https://www.globenewswire.com/news-release/2020/08/14/2078641/0/en/Revive-Therapeutics-Signs-MOU-with-Attwill-Medical-Solutions-for-Phase-3-Clinical-Trial-for-Bucillamine-in-COVID-19.html